ClinicalTrials.govpublic full text
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
adjuvant chemotherapy, ovarian neoplasms, ovarian cancer, peg-rhg-csf, secondary prophylaxis, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857337
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.